CD4 and autoimmune hepatitis: These studies will help determine the complex mechanisms and key targets of CD4+ T-cell subsets involved in the progression of AIH, providing theoretical guidance in identifying new biomarkers of AIH and discovering more effective and safer therapeutic targets to replace the current long-term immunosuppressive therapy, which is known to have serious side effects.